For the quarter ended September 2024, Globus Medical (GMED) reported revenue of $625.71 million, up 63.1% over the same period last year. EPS came in at $0.83, compared to $0.57 in the year-ago quarter.The reported revenue represents a surprise of +3.44% over the Zacks Consensus Estimate of $604.93 million. With the consensus EPS estimate being $0.65, the EPS surprise was +27.69%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

Globus Medical (GMED) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.57 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 27.69%. A quarter ago, it was expected that this medical device company would post earnings of $0.68 per share when it actually produced earnings of $0.75, delivering a surprise of 10.29%.Over the last four quarters ...

AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2024. Worldwide net sales were $625.7 million, an increase of 63.1%GAAP net income for the quarter was $51.8 millionGAAP diluted earnings per share (“EPS”) was $0.38 and non-GAAP diluted EPS was $0.83Non-GAAP adjusted EBITDA was $193.7 million, or 31.0% of net sales “Our third quarter results reflect the endu ...

The upcoming report from Globus Medical (GMED) is expected to reveal quarterly earnings of $0.65 per share, indicating an increase of 14% compared to the year-ago period. Analysts forecast revenues of $604.93 million, representing an increase of 57.7% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings announcement ...

Globus Medical, Inc.’s (GMED) merger with NuVasive is expected to generate significant synergies, enhance its globalization initiatives, expand customer access and bolster ties with surgeons. The company is making a string of product introductions, which is highly promising for the coming quarters. Its robust prospect in the musculoskeletal space also bodes well for continued growth. However, the impacts of macroeconomic challenges and pricing pressure raise concerns about the company’s operational results. ...

AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eas ...

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estima ...

A month has gone by since the last earnings report for Globus Medical (GMED) . Shares have lost about 0.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Globus Medical due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Globus Medical Q2 Earnings Surpass, Raises ...

LOS ANGELES, Aug. 23, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE: GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Globus disclosed in an August 13, 2024, SEC filing that, "on July 16, 2024, Glo ...

Globus Medical, Inc. (GMED) recently announced the commercial launch of the ADIRA XLIF Plate System — the first product to be compatible with the company's expanded lateral interbody portfolio. With the latest launch, GMED has achieved a milestone in its integration journey. This should help the company to boost its procedural innovation in lateral spine surgery. About ADIRA XLIF Plate System The ADIRA XLIF Plate System redefines lateral plating by offering simplified insertion workflows and a rigid couplin ...